4//SEC Filing
Cara Therapeutics, Inc. 4
Accession 0001209191-15-059607
$TVRDCIK 0001346830operating
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 5:03 PM ET
Size
4.8 KB
Accession
0001209191-15-059607
Insider Transaction Report
Form 4
Lewis Michael E
Chief Scientific Advisor
Transactions
- Sale
Common Stock
2015-07-01$11.66/sh−7,262$84,675→ 322,250 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2014.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001346830
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 5:03 PM ET
- Size
- 4.8 KB